Nordic Countries Oncology Market Analysis: Cancer Diagnostics and Cancer Treatment Drugs, Therapy, Applications (Blood Cancer, Lung Cancer, Colorectal Cancer, Breast Cancer, Liver Cancer, Bladder Cancer, Head & Neck Cancer, Prostate Cancer, and Others), Countries: Sweden, Norway, Denmark, Finland and others

Nordic Countries Oncology market size is estimates to be $XX million in 2022. According to the finalized cancer statistics from the Finnish Cancer Registry, there were 12,730 cancer deaths and 34,372 new cases of cancer in 2018 in Finland. The most frequent cancer in both men and women is still prostate cancer in men and breast cancer in women. People with a basic education had the highest rate of new cases and cancer deaths, while those with tertiary education had the lowest rate. At the end of 2018, there were 11,500 people over the age of 70 who had received a cancer diagnosis less than a year earlier, according to t too registered data. the percentage of people over 70. Also 160 000 people had received a cancer diagnosis at some time in their life.

In Finland, a total of 34 372 new cancer cases were identified in 2018. Of these, 17 836 men and 16 536 women had the diagnosis. 12 730 people lost their lives to cancer in 2018.

Lung cancer treatment outcomes are poorer in Finland than in other Nordic nations, according to a new study analyzing Nordic statistics. About 13% of men and 19% of women in Finland are still alive five years after receiving their diagnosis. Men are less likely to develop lung cancer than women, according to data from the Finnish Cancer Registry. Lung cancer has, however, become more prevalent among women. Women who don’t smoke have seen an alarming rise in lung cancer cases in recent years. It’s unclear what caused this specifically.

More than 80% of the women who are invited to the event are screened. Less than 3% of participants are selected for additional testing, such as an ultrasound and a biopsy, and in these circumstances, 20% of the participants had breast cancer.

According to the most recent WHO, in 2020 Finland has a record of 545 or 1.13% mortalities from liver Cancer. Finland ranks #131 in the world with a 4.01 per 100,000 people age-adjusted death rate.

According to the most recent WHO data, in 2020 Finland has a record of 308 or 0.64% modalities from bladder Cancer. Finland ranks #97 in the world with a 1.97 per 100,000 people age-adjusted death rate.

Like other Northern European nations, Finland has extremely high incidence rates, and death there is also higher than the global norm. With about 5000 new cases in 2018, prostate cancer is the most prevalent cancer in Finland for both men and overall (Finnish Cancer Registry). With almost 900 fatalities in 2018, it comes in second place overall and after lung cancer among men in terms of the number of cancer deaths. Overall, Finland has a positive prognosis for prostate cancer, with a relative survival ratio of more than 90% after five years.

Nordic Countries Oncology Market by States

• Sweden
• Norway
• Denmark
• Finland
• others

Nordic Countries oncology market has been spilt into countries namely Sweden, Norway, Denmark, Finland and others.

Nordic Countries Oncology Market Segments

Datavagyanik has covered each oncology in detail in terms of market size, sales volume, growth forecast. The segment and sub segment level categorization covered in the report are:

• Cancer Diagnostics
  • Biopsy
  • Imaging
  • Immunohistochemistry
  • Tumor Biomarkers Test
  • In Situ Hybridization
  • Liquid Biopsy
• Cancer Treatment Drugs (Revlimid, Avastin, Herceptin, Rituxan, Opdivo, Gleevec, Velcade, Imbruvica, Ibrance, Zytiga, Alimta, Xtandi, Tarceva, Perjeta, Temodar, and Others)
  • Cancer Treatment Therapy
    • Targeted Therapy
    • Chemotherapy
    • Hormonal Therapy
    • Immunotherapy
    • Others
  • Applications
    • Blood Cancer
    • Lung Cancer
    • Colorectal Cancer
    • Breast Cancer
    • Liver Cancer
    • Bladder Cancer
    • Head & Neck Cancer
    • Prostate Cancer
    • Others

Key questions answered in the Nordic Countries Oncology Market Analysis Report:

• What is the overall oncology market size in Nordic Countries and how is the demand rising and what is market for each cancer type (Blood Cancer, Lung Cancer, Colorectal Cancer, Breast Cancer, Liver Cancer, Bladder Cancer, Head & Neck Cancer, Prostate Cancer, Others)?
• What is the market size for cancer diagnostics (Biopsy, Imaging, Immunohistochemistry, Tumor, Biomarkers Test, In Situ Hybridization, Liquid Biopsy) in Nordic Countries?
• What is the market size for cancer treatment drugs (Revlimid, Avastin, Herceptin, Rituxan, Opdivo, Gleevec, Velcade, Imbruvica, Ibrance, Zytiga, Alimta, Xtandi, Tarceva, Perjeta, Temodar, and Others) in Nordic Countries?
• What is the market size for cancer treatment by therapy (Targeted Therapy, Chemotherapy, Hormonal Therapy, Immunotherapy, Others) in Nordic Countries?
• Who are the top market players by market share, in each product segment?
• Which is the fastest growing business/ product segment?
• What should be the business strategies and Go to Market strategies?

Oncology in Nordic Countries: Report Deliverables

1. Summary Statistics
   • Oncology in Nordic Countries Market Attractiveness Analysis

• Oncology Diagnostics Market
• Oncology Drugs
• Therapies/Treatment Type

1. Oncology in Nordic Countries Market Analysis, by Segment (state level analysis)
   • Overview
   • Historical Market size ($Million), (2017 – 2021)
   • Market size ($Million), and Forecasts (2022 – 2027)
2. Market Analysis by Segment (state level analysis)
   • End Users (Hospitals, Diagnostics Centers, others)
   • Application (Blood Cancer, Lung Cancer, Colorectal Cancer, Breast Cancer, Liver Cancer, Bladder Cancer, Head & Neck Cancer, Prostate Cancer, Others)
3. Region wise analysis

• Sweden revenue & volume (Cancer Diagnostics and Cancer Treatment Drugs, Therapy)
• Norway revenue & volume (Cancer Diagnostics and Cancer Treatment Drugs, Therapy)
• Denmark revenue & volume (Cancer Diagnostics and Cancer Treatment Drugs, Therapy)
• Finland revenue & volume (Cancer Diagnostics and Cancer Treatment Drugs, Therapy)
• Rest of Nordic countries revenue & volume (Cancer Diagnostics and Cancer Treatment Drugs, Therapy)

5. Pricing analysis
   • Cancer diagnostics and treatment cost in Nordic Countries
   • Cancer drug cost in Nordic Countries
6. Market forecast for 10 years
7. Investment strategies